Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 2/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||H008259 / 1||UN / UN|
|TDAP: TDAP (BOOSTRIX) / GLAXOSMITHKLINE BIOLOGICALS||- / -||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Anxiety, Cystitis, Depression, Dizziness, Fatigue, Feeling abnormal, Headache, Insomnia, Menstrual disorder, Motion sickness, Muscular weakness, Nausea, Ovarian cyst ruptured, Rash, Skin striae, Syncope, Tonsillitis, Activities of daily living impaired, Gastric disorder, Oropharyngeal pain
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? Yes
Other Medications: No other medications
Current Illness: Immunisation
Diagnostic Lab Data:
CDC 'Split Type': WAES1610IRL003237
Write-up:Information has been received from Sanofi Pasteur MSD (SPM) MFR# IE-1577272925-2016010019) on 07-OCT-2016. This report was received from RA on 04-OCT-2016 under reference number IE-HPRA-2016-027923. Initial Case received from a consumer/non health professional which concerns a 12-year-old female adolescent patient received the first dose of GARDASIL (batch number G019345) via intravenous route on 17-Sep-2012 and the second dose of GARDASIL (batch number H008259) on 12-Nov-2012 and BOOSTRIX on 12-Nov-2012. The patient experienced chronic fatigue, muscle weakness, chronic gastric disturbance, fainting, dizziness, brain fog, headaches, recurring sore throat, tonsillitis, anxiety, depression, insomnia, cystitis, rash, stretch marks, ruptured ovarian cyst and ongoing menstruated issues on 10-Aug-2014, 636 days Post Administration; nausea and motion sickness on an unknown date. Corrective treatment: The patient has ongoing visits to GPs, hospitals and specialists. The reporter indicated that the patient has missed long periods of school and her symptoms are disabling her. The patient''s outcome was reported as Not Recovered/Not Resolved. The reporter assessed the causal relationship: -between Chronic fatigue and GARDASIL as Unknown -between Muscle weakness and GARDASIL as Unknown -between Gastric disorder and GARDASIL as Unknown -between Fainting and GARDASIL as Unknown -between Dizziness and GARDASIL as Unknown -between Foggy feeling in head and GARDASIL as Unknown -Headache and GARDASIL as Unknown -between Sore throat and GARDASIL as Unknown -between Tonsillitis and GARDASIL as Unknown -between Anxiety and GARDASIL as Unknown -between Depression and GARDASIL as Unknown -between Insomnia and GARDASIL as Unknown -between Cystitis and GARDASIL as Unknown -between Rash and GARDASIL as Unknown -between Stretch marks and GARDASIL as Unknown -between Ovarian cyst ruptured and GARDASIL as Unknown -between Menstrual cycle abnormal and GARDASIL as Unknown -between Nausea and GARDASIL as Unknown -between Motion sickness and GARDASIL as Unknown. Upon our internal review, BOOSTRIX was added as a suspect vaccine as it was given on the same day with the second dose of GARDASIL vaccine.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166